Foghorn Therapeutics (FHTX) Short Interest Ratio & Short Volume → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free FHTX Stock Alerts $5.98 +0.35 (+6.22%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Foghorn Therapeutics Short Interest DataCurrent Short Volume1,180,000 sharesPrevious Short Volume1,190,000 sharesChange Vs. Previous Month-0.84%Dollar Volume Sold Short$7.54 millionShort Interest Ratio / Days to Cover7.4Last Record DateApril 15, 2024Outstanding Shares42,570,000 sharesFloat Size18,710,000 sharesShort Percent of Float6.31%Today's Trading Volume55,696 sharesAverage Trading Volume138,351 sharesToday's Volume Vs. Average40% Short Selling Foghorn Therapeutics ? Sign up to receive the latest short interest report for Foghorn Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFHTX Short Interest Over TimeFHTX Days to Cover Over TimeFHTX Percentage of Float Shorted Over Time Ad TradeSmithThe A.I. story nobody is telling you (Read ASAP)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...Click here to see Louis' new video for yourself. Foghorn Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,180,000 shares $7.54 million -0.8%6.3%7.4 $6.39 3/31/20241,190,000 shares $7.98 million -4.8%6.4%7.4 $6.71 3/15/20241,250,000 shares $7.39 million No Change6.8%7.7 $5.91 2/29/20241,250,000 shares $9.66 million -8.8%6.8%7.5 $7.73 2/15/20241,370,000 shares $9.33 million +29.3%7.5%8.7 $6.81 1/31/20241,060,000 shares $3.37 million +16.2%6.0%7.7 $3.18 Get the Latest News and Ratings for FHTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Foghorn Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024912,600 shares $4.80 million -0.2%5.2%9.5 $5.26 12/31/2023914,200 shares $5.90 million -8.0%5.2%9.2 $6.45 12/15/2023994,100 shares $5.26 million -3.5%5.7%9.4 $5.29 11/30/20231,030,000 shares $4.38 million -1.0%5.9%10.4 $4.25 11/15/20231,040,000 shares $4.17 million -23.5%6.0%10.3 $4.01 10/31/20231,360,000 shares $4.56 million +17.2%7.8%14.7 $3.35 10/15/20231,160,000 shares $4.05 million -28.8%6.7%13.9 $3.49 9/30/20231,630,000 shares $8.15 million -2.4%9.5%20.9 $5.00 9/15/20231,670,000 shares $10.87 million -5.1%9.7%25.5 $6.51 8/31/20231,760,000 shares $13.32 million -15.4%9.8%23.6 $7.57 8/15/20232,080,000 shares $20.53 million No Change11.6%28.6 $9.87 7/31/20232,080,000 shares $19.05 million -3.3%11.8%24.7 $9.16 7/15/20232,150,000 shares $16.77 million +1.4%12.4%23.1 $7.80 6/30/20232,120,000 shares $14.92 million +1.0%12.1%21.5 $7.04 6/15/20232,100,000 shares $17.87 million -0.9%12.0%22.3 $8.51 5/31/20232,120,000 shares $13.33 million -0.9%12.1%24.7 $6.29 5/15/20232,140,000 shares $13.80 million +3.9%12.2%26.7 $6.45 4/30/20232,060,000 shares $13.43 million No Change11.7%27.4 $6.52 4/15/20232,060,000 shares $14.75 million -5.9%11.7%30.7 $7.16 3/31/20232,190,000 shares $13.58 million +3.3%12.5%32.1 $6.20 3/15/20232,120,000 shares $10.41 million +3.9%12.1%31 $4.91 2/28/20232,040,000 shares $11.69 million +3.6%11.6%27.3 $5.73 2/15/20231,970,000 shares $12.27 million +5.9%11.2%24.5 $6.23 1/31/20231,860,000 shares $16.00 million +0.5%10.6%21.8 $8.60 1/15/20231,850,000 shares $16.11 million -2.1%10.6%20.9 $8.71 12/30/20221,890,000 shares $12.06 million +3.3%10.8%23.7 $6.38 12/15/20221,830,000 shares $11.75 million +0.6%10.4%22.9 $6.42 11/30/20221,820,000 shares $12.29 million -6.7%10.4%23.2 $6.75 11/15/20221,950,000 shares $18.00 million -22.6%11.2%24.3 $9.23 10/31/20222,520,000 shares $22.02 million +2.4%14.1%26.9 $8.74 10/15/20222,460,000 shares $18.23 million -0.8%13.8%25.9 $7.41 9/30/20222,480,000 shares $21.28 million +0.8%13.9%25.5 $8.58 9/15/20222,460,000 shares $24.43 million +2.1%13.8%23.6 $9.93 8/31/20222,410,000 shares $23.96 million -11.4%13.5%21.7 $9.94How Biden has already won 2024 (Ad)Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. FHTX Short Interest - Frequently Asked Questions What is Foghorn Therapeutics' current short interest? Short interest is the volume of Foghorn Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 1,180,000 shares of FHTX short. 6.31% of Foghorn Therapeutics' shares are currently sold short. Learn More on Foghorn Therapeutics' current short interest. What is a good short interest ratio for Foghorn Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FHTX shares currently have a short interest ratio of 7.0. Learn More on Foghorn Therapeutics's short interest ratio. What is a good short interest percentage for Foghorn Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.31% of Foghorn Therapeutics' floating shares are currently sold short. Is Foghorn Therapeutics' short interest increasing or decreasing? Foghorn Therapeutics saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 1,180,000 shares, a drop of 0.8% from the previous total of 1,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Foghorn Therapeutics' float size? Foghorn Therapeutics currently has issued a total of 42,570,000 shares. Some of Foghorn Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Foghorn Therapeutics currently has a public float of 18,710,000 shares. How does Foghorn Therapeutics' short interest compare to its competitors? 6.31% of Foghorn Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Foghorn Therapeutics: 23andMe Holding Co. (10.48%), Veru Inc. (7.55%), Conduit Pharmaceuticals Inc. (0.40%), AC Immune SA (0.89%), Aldeyra Therapeutics, Inc (4.17%), Werewolf Therapeutics, Inc. (1.40%), Emergent BioSolutions Inc. (11.76%), uniQure (5.90%), Puma Biotechnology, Inc. (9.60%), Zevra Therapeutics, Inc. (5.93%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Foghorn Therapeutics stock? Short selling FHTX is an investing strategy that aims to generate trading profit from Foghorn Therapeutics as its price is falling. FHTX shares are trading up $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Foghorn Therapeutics? A short squeeze for Foghorn Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FHTX, which in turn drives the price of the stock up even further. How often is Foghorn Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FHTX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 23andMe Short Interest Data Veru Short Interest Data Conduit Pharmaceuticals Short Interest Data AC Immune Short Interest Data Aldeyra Therapeutics Short Interest Data Werewolf Therapeutics Short Interest Data Emergent BioSolutions Short Interest Data uniQure Short Interest Data Puma Biotechnology Short Interest Data Zevra Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FHTX) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders